FFCP PHASE1:Mm9::chr19:40740409..40740421,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=6|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr19:40740409..40740421,-|id=chr19:40740409..40740421,-|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=CL:0000355,4.60e-15,9|ontology_enrichment_disease=DOID:0060100!3.66e-16!3;DOID:4045!3.66e-16!3;DOID:0050686!2.47e-08!6|ontology_enrichment_disease_v019_2=DOID:0060100,2.45e-43,3;DOID:4045,2.45e-43,3;DOID:0050686,3.68e-22,6|ontology_enrichment_uberon=UBERON:0002204!4.94e-07!32|ontology_enrichment_uberon_v019_2=UBERON:0001134,4.60e-15,9;UBERON:0002036,4.60e-15,9;UBERON:0002385,4.60e-15,9;UBERON:0000486,4.60e-15,9;UBERON:0007503,4.60e-15,9;UBERON:0001015,4.60e-15,9;UBERON:0002329,4.60e-15,9;UBERON:0003082,4.60e-15,9;UBERON:0003059,4.60e-15,9;UBERON:0007282,4.60e-15,9;UBERON:0004290,4.60e-15,9;UBERON:0009618,4.60e-15,9;UBERON:0000383,1.22e-13,10;UBERON:0007524,1.80e-12,11;UBERON:0003077,1.80e-12,11;UBERON:0007285,1.80e-12,11|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.157731082679119,0,0.42438965179803,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.4409111995798,5.4693474116666,1.57057123192139,32.3527318417058,24.589637458504,13.5942898848723,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.124406970610093,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.257347907114715,0.284163499395593,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.184753190166605,0,0,0,0,0,0,0,0.157635144106191,0,0,0.491589944147214,0,0.144649058581512,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0603129249281559,0,0,0,0,0,0,0,0,0.136694227721025,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.100966449948148,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr19:40740409..40740421,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=6 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr19:40740409..40740421,- | |||
|description=CAGE_peak_at_chr19:40740409..40740421,- | |||
|id=chr19:40740409..40740421,- | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2=CL:0000355,4.60e-15,9 | |||
|ontology_enrichment_disease=DOID:0060100!3.66e-16!3;DOID:4045!3.66e-16!3;DOID:0050686!2.47e-08!6 | |||
|ontology_enrichment_disease_v019_2=DOID:0060100,2.45e-43,3;DOID:4045,2.45e-43,3;DOID:0050686,3.68e-22,6 | |||
|ontology_enrichment_uberon=UBERON:0002204!4.94e-07!32 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,4.60e-15,9;UBERON:0002036,4.60e-15,9;UBERON:0002385,4.60e-15,9;UBERON:0000486,4.60e-15,9;UBERON:0007503,4.60e-15,9;UBERON:0001015,4.60e-15,9;UBERON:0002329,4.60e-15,9;UBERON:0003082,4.60e-15,9;UBERON:0003059,4.60e-15,9;UBERON:0007282,4.60e-15,9;UBERON:0004290,4.60e-15,9;UBERON:0009618,4.60e-15,9;UBERON:0000383,1.22e-13,10;UBERON:0007524,1.80e-12,11;UBERON:0003077,1.80e-12,11;UBERON:0007285,1.80e-12,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.157731082679119,0,0.42438965179803,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.4409111995798,5.4693474116666,1.57057123192139,32.3527318417058,24.589637458504,13.5942898848723,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.124406970610093,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.257347907114715,0.284163499395593,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.184753190166605,0,0,0,0,0,0,0,0.157635144106191,0,0,0.491589944147214,0,0.144649058581512,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0603129249281559,0,0,0,0,0,0,0,0,0.136694227721025,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.100966449948148,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr19:40740409..40740421,- | |||
}} |
Latest revision as of 01:50, 4 August 2015
Short description: | p@chr19:40740409..40740421, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr19:40740409..40740421, - |
Coexpression cluster: | MCL_coexpression_mm9:6 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
multi-potent skeletal muscle stem cell | 4.60e-15 | 9 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 4.60e-15 | 9 |
striated muscle tissue | 4.60e-15 | 9 |
muscle tissue | 4.60e-15 | 9 |
multilaminar epithelium | 4.60e-15 | 9 |
epithelial vesicle | 4.60e-15 | 9 |
musculature | 4.60e-15 | 9 |
somite | 4.60e-15 | 9 |
myotome | 4.60e-15 | 9 |
presomitic mesoderm | 4.60e-15 | 9 |
presumptive segmental plate | 4.60e-15 | 9 |
dermomyotome | 4.60e-15 | 9 |
trunk paraxial mesoderm | 4.60e-15 | 9 |
musculature of body | 1.22e-13 | 10 |
dense mesenchyme tissue | 1.80e-12 | 11 |
paraxial mesoderm | 1.80e-12 | 11 |
presumptive paraxial mesoderm | 1.80e-12 | 11 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 2.45e-43 | 3 |
muscle cancer | 2.45e-43 | 3 |
organ system cancer | 3.68e-22 | 6 |